Skip to main content
QXL Diagnostics
Pregnancy & Women's Health Verified Clinical Guide

HPV DNA Test in Bengaluru: Purpose, Preparation & Results

Assigned medical reviewer: Dr. Ajitha PillaiMD (Microbiology), Senior Consultant Microbiologist
October 20, 2026
5 min read
20 Sections
HPV DNA Test in Bengaluru: Purpose, Preparation & Results - QXL Diagnostics Bengaluru
Share Clinical Guide:
High-risk HPV DNA testing detects selected cancer-associated HPV types in a cervical screening or follow-up sample. A positive result does not itself diagnose cancer; genotype, cytology and previous history determine the next step.

Quick answer: High-risk HPV DNA testing detects selected cancer-associated HPV types in a cervical screening or follow-up sample. A positive result does not itself diagnose cancer; genotype, cytology and previous history determine the next step. It is not a general test of every HPV infection. QXL must confirm its assay coverage and approved collection setting in Bengaluru.

Also known as: HPV PCR, hrHPV DNA, HPV16 HPV18

What is the High-Risk HPV DNA Test test used for?#

  • Clinician-selected cervical screening based on age, history and locally applicable guidance.
  • Follow-up or triage of specified abnormal cervical screening results.
  • Co-testing with cytology where appropriate to the clinical pathway.

Conditions it helps investigate: High-risk HPV infection

What does the test measure?#

  • High-risk HPV DNA: Genetic material from oncogenic HPV types included in the selected assay.
  • Genotype information, if the assay provides it: Some assays identify HPV16/18 separately and pool other types; the exact QXL coverage must be confirmed.

How is it tested?#

General principle: a validated molecular assay detects targeted high-risk HPV DNA, often using real-time PCR. Genotype coverage and reporting vary. QXL must verify the specific assay and approved sample type; DNA testing must not be confused with an HPV mRNA assay.

Sample and preparation#

Specimen: Clinician-collected cervical cells in assay-approved transport medium. A self-collected sample is acceptable only if specifically validated and offered within an approved QXL pathway.

  • Arrange collection with a trained clinician and provide previous Pap/HPV results and treatment history.
  • Tell the clinician about pregnancy, bleeding or symptoms before collection.
  • Confirm instructions about menstruation, intercourse and intravaginal products for the actual collection method.
  • No fasting is generally required.
Specimen detailWhat to confirm
VolumePending QXL assay/SOP confirmation.
ContainerPending QXL assay/SOP confirmation; use the approved collection kit.
StabilityPending QXL validated time/temperature and transport instructions.
RejectionQXL to confirm assay-specific rejection rules; identifier mismatch, unsuitable container or compromised sample requires laboratory review.

How are the results interpreted?#

  • Positive means a targeted high-risk HPV type was detected; it does not mean cancer is present.
  • Follow-up depends on genotype, cytology, age and prior history, not the HPV result in isolation.
  • A negative result lowers risk for the targeted types but does not explain symptoms or exclude all cervical disease.

Reference interval: Use the QXL report’s assay-specific units, reference interval or decision limit. Age, sex, pregnancy, sampling time and clinical context may change interpretation; there is no universal range for this page.

What are the limitations?#

  • Not a general test for every HPV type, body site or sexually transmitted infection.
  • Cannot determine exactly when infection was acquired or which partner transmitted it.
  • Sampling adequacy and assay coverage affect detection.
  • Symptoms such as unexplained bleeding need clinical assessment even with a negative screening result.

How does it compare with other tests?#

  • HPV testing detects viral DNA. Pap/LBC detects cell changes. Colposcopy and biopsy investigate selected abnormal findings.

Notes for referring clinicians#

Provide the diagnostic question, prior results and relevant treatment. Confirm the exact assay, specimen SOP and performing laboratory. Discuss results that conflict with the clinical picture before changing management.

Price, report time and home collection#

  • Price: Price requires QXL approval; no unverified price is offered.
  • Report time: QXL test-specific turnaround pending confirmation; do not infer from another laboratory.
  • Home collection: HPV collection eligibility depends on the validated specimen and assay. Confirm trained cervical collection or an explicitly supported self-sampling kit; do not substitute an ordinary home swab.
  • Processing: QXL to confirm in-house versus referral processing and assay/platform.
  • Report review: Proposed reviewer assignment only. Medical review, operations verification and sign-off are pending.

Call +91 9964 639 639 or WhatsApp QXL to confirm the current quote, preparation and collection slot.

Frequently asked questions#

Does a positive HPV DNA result mean cancer?#

No. It identifies a targeted high-risk infection. The clinician decides whether repeat testing, cytology or colposcopy is needed.

Is HPV DNA testing the same as a Pap test?#

No. HPV DNA testing looks for viral genetic material; Pap cytology examines cervical cells for abnormal changes.

Will the test identify the HPV type?#

Some assays identify specific types and group the others. Ask QXL which genotypes its selected assay reports.

Can this tell when I acquired HPV?#

No. A positive test cannot reliably date infection or identify its source.

Does HPV vaccination remove the need for screening?#

Vaccination does not replace an appropriate cervical screening plan. Discuss the interval with your clinician.

Can I collect a sample at home?#

Only use self-collection if the exact assay and service support it. A cervical collection appointment must not be replaced with an unvalidated home swab.

Do I need to fast or stop medicines?#

Fasting is generally unnecessary. Confirm any collection preparation or intravaginal-product restrictions with the collecting clinician; do not stop treatment on your own.

What if the result is negative but I have bleeding?#

Screening is not a substitute for assessing symptoms. Seek clinical review of unexplained bleeding, pain or discharge.

Sources#

  • Clinical principles are supported by the cited textbook sections and current primary guidance; actual QXL kit, specimen volume, stability, price, turnaround and availability remain unverified.

Educational information only; not a diagnosis or a substitute for a doctor’s advice.

Medical & Laboratory Disclaimer

Medical information notice: This article is for general educational purposes and does not diagnose disease or replace consultation with a qualified healthcare professional. Test selection, preparation and interpretation should be based on individual clinical circumstances.

Assigned Medical Reviewer

Dr. Ajitha Pillai

MD (Microbiology), Senior Consultant Microbiologist

QXL Clinical Editorial Commitment: Every health guide, biomarker explanation, and screening schedule published on this portal undergoes rigorous clinical review by qualified MD pathologists and biochemists to ensure adherence to peer-reviewed evidence (ACOG, WHO, ICMR) and laboratory diagnostic accuracy.

Share Clinical Guide:

Related Clinical Guides

Explore more evidence-based diagnostic articles and testing guidelines